sameAs
Challenges in long-term mechanical circulatory support and biological replacement of the failing heartIs heart failure with preserved systolic function an overlooked enigma?Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceCrossing the vasculopathy bridge from morphology to therapy: a single center experience.Targeted in vitro and in vivo gene transfer into T lymphocytes: potential of direct inhibition of allo-immune activationSafety and clinical utility of long-term intravenous milrinone in advanced heart failure.New data on the clinical impact of exercise training, fish oils, and statins in heart failure.Chronic heart failure: contemporary diagnosis and managementComparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study)Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s.Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.Calcineurin-inhibitor withdrawal in heart transplantation recipients (the case against).Treatment of pulmonary hypertension: a promising new age.Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registryHeart failure therapy at a crossroad: are there limits to the neurohormonal model?Treatment of hypertension for patients with diastolic dysfunction.B-type natriuretic peptide in heart transplantation: an important marker of allograft performance.Cardiac troponin levels in heart failure.Destination therapy in late-stage heart failure.Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes.Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure.Early recognition and treatment of hypertensive heart disease.The emergence of genomic and proteomic biomarkers in heart transplantation.The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside.Ancient Egyptian medicine and the concept of heart failure.Understanding the basics of cardiopulmonary exercise testing.Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomesSexual activity and chronic heart failure.Surgery for severe mitral regurgitation and left ventricular failure: what do we really know?Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment.Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.Cardiomyopathy and the dilemma of geometric mitral regurgitation.Heart transplantation research in the next decade--a goal to achieving evidence-based outcomes: National Heart, Lung, And Blood Institute Working GroupGeneric drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.Gene-based bio-signature patterns and cardiac allograft rejection.Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF.Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
P50
Q26823634-A6261C74-AED7-47A4-8880-363C4A129EE1Q30330168-6C05D26F-6E70-400B-AE76-FEA5906FE0B7Q30415384-7C9D6FF4-DA94-4389-ABE1-12160ACF0B91Q30655559-750FB92C-2F65-4540-8470-F3D88EC82568Q33263272-BD981013-6E38-47C4-93D0-68515722C73CQ33499672-F80400AE-7ACE-41C4-BFDF-4C42ED7F954BQ33521834-49883D8B-DDCC-4EC8-AE59-F8708A32492AQ33620431-5FE298B7-7B1D-4F12-AC0C-9D66A6B0D61CQ34084299-DCC1E1AC-9D8E-4B61-9AC3-FAE1901831D0Q34161006-F4EF0C41-31C8-4633-8325-A335ADD31B3CQ34323044-7E306636-3BB4-47E1-9141-4F295E2A8900Q34487603-B0B0423D-2D9D-4CEA-A306-D16719445E06Q34564840-020EDE58-52B0-405D-8E2C-A0198C427E1FQ34784767-87854F68-653D-47F6-8F7D-465B5FC6FD8EQ34985847-8FF863AF-0B9A-463E-8CE2-A8FB2C79237EQ35056559-2886F44B-DA0C-4DFA-A4B1-3E6C0820F0FEQ35125701-2AD01410-3544-4D02-AE0A-E51D1148D88CQ35176603-4298BE88-E187-469C-8716-D39131D24017Q35566143-93928490-2D87-4701-BA10-61F3A61CFE76Q35604623-C319296D-DAC5-49FB-94AF-BA79EF90B0B9Q35692559-79D00360-6605-4090-8480-4568B5114538Q36117344-90C24B1B-AA4E-438E-8DE2-757098138A0FQ36130511-86046D78-3648-4076-9714-0F8939CA6EF5Q36163396-18619EB5-1AA8-45B5-B53D-01F0B2138A8CQ36182236-32266C5B-D1F0-4BAA-AFEE-8205908C72C1Q36408463-FEF11E05-1C4E-41EB-A4ED-1F02EED50963Q36567011-AAEB962A-7437-4BCE-A4F9-960C80728BE9Q36682231-349E3BE5-10CF-4F8E-BA99-21720E4182C3Q36776529-176061D5-24A1-4373-8602-244A2418C4E5Q36956977-1A05489B-EE6F-4AD3-AFFC-B676A00EE546Q37104129-F06541E1-6E83-4C47-842D-667C60BC7239Q37369362-AD921B58-01B6-4969-BB78-A5F14B254CACQ37479004-14BA6F90-2903-48FB-BA6B-061C52599B1FQ37489752-CB3D54B4-8D76-4892-927D-F11233A828C6Q37521857-3269B3ED-C04E-4CA2-8248-EB683D0EEAEDQ37524481-9C43D0D0-92F2-4DFF-9585-9AF854DA7C0BQ37533595-24CA78A6-A333-48BD-8C77-276F71089AF7Q37640668-D55AD3C9-D865-42A9-AF06-F34861B9EADAQ37643914-DFD4D269-9DCA-486F-82F9-821B669192B4Q37710255-22DB2B01-BEFF-40C8-8B08-7F6B81F6C038
P50
description
American academic
@en
editor estadounidense
@es
editor estauxunidense
@ast
onderzoeker
@nl
հետազոտող
@hy
name
Mandeep R. Mehra
@ast
Mandeep R. Mehra
@ca
Mandeep R. Mehra
@de
Mandeep R. Mehra
@en
Mandeep R. Mehra
@es
Mandeep R. Mehra
@fr
Mandeep R. Mehra
@it
Mandeep R. Mehra
@sl
type
label
Mandeep R. Mehra
@ast
Mandeep R. Mehra
@ca
Mandeep R. Mehra
@de
Mandeep R. Mehra
@en
Mandeep R. Mehra
@es
Mandeep R. Mehra
@fr
Mandeep R. Mehra
@it
Mandeep R. Mehra
@sl
prefLabel
Mandeep R. Mehra
@ast
Mandeep R. Mehra
@ca
Mandeep R. Mehra
@de
Mandeep R. Mehra
@en
Mandeep R. Mehra
@es
Mandeep R. Mehra
@fr
Mandeep R. Mehra
@it
Mandeep R. Mehra
@sl
P106
P1153
7102944106
P19
P21
P31
P496
0000-0001-8683-7044
P5008
P569
1964-12-03T00:00:00Z